Biodesix.com

Site Inspections

Overview & More informations

**Biodesix, Inc. (biodesix.com)** is a molecular diagnostics company advancing the development and commercialization of blood-based tests for earlier detection and monitoring of critical conditions, including lung, breast, colon, and prostate cancers, and chronic kidney disease. The company's mission is to provide molecular insights that improve patient outcomes and reduce the cost of healthcare.

Biodesix's proprietary GeneStrat**™** and VeriStrat**™** platforms use a variety of molecular technologies, including real-time PCR, next-generation sequencing, and multiplex immunoassays, to analyze cell-free nucleic acids (cfNAs), circulating tumor cells (CTCs), and proteins in blood. The company's tests are designed to provide clinicians with actionable information that can be used to guide treatment decisions, monitor disease progression, and predict response to therapy.

Biodesix's tests are used by clinicians in a variety of settings, including academic medical centers, community hospitals, and reference laboratories. The company has a strong track record of clinical validation and has published numerous peer-reviewed studies in leading medical journals.

In addition to its commercial operations, Biodesix is also engaged in a number of research and development programs. The company is developing new tests for the early detection and monitoring of a variety of cancers and chronic diseases. Biodesix is also working to develop companion diagnostics that can be used to guide treatment decisions for patients with specific genetic mutations.

Biodesix is a publicly traded company headquartered in Boulder, Colorado. The company has a team of experienced scientists, engineers, and business professionals who are dedicated to advancing the field of molecular diagnostics.

Domains Expiration Date Updated